Buy & Sell AstraZeneca plc (AZN) – AstraZeneca plc Price Today
Aura AI Summary
Key Stats
- $291.78BMarket Cap
- HealthSector
- -13.05%3M Drawdown
- $318.02BEnterprise Value
- 1.67%Dividend Yield
- 58% Buy | 42% SellTrading Activity
- 123 daysTypical Hold Time
AstraZeneca plc (AZN) is currently valued at a market capitalization of $291.78B, with an enterprise value of $318.02B. Over the past 52 weeks, AstraZeneca plc has traded between a low of $137.44 and a high of $209.48, highlighting its annual price range. Over the past three months, AstraZeneca plc has recorded a drawdown of -13.05%, reflecting recent price volatility. AstraZeneca plc offers a dividend yield of 1.67%, with the most recent dividend of $1.60 paid on 20 Feb 26. On average, investors hold AstraZeneca plc for approximately 123 days, indicating typical investor behavior on the platform.
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Most Recent News
Oura's IPO tests if wellness tech can thrive in public markets amid shifting digital health trends.
Oura Health is preparing for an IPO that could indicate whether public markets are ready to support consumer-focused digital health companies. Unlike earlier wearables focused on hardware sales, Oura emphasizes a subscription model offering health in...

Meta's $125B AI investment sparks investor concern amid rising costs and layoffs
Meta has raised its 2026 capital expenditure guidance to $125-$145 billion, nearly five times last year's $28 billion, focusing heavily on AI infrastructure. Despite strong ad revenue growth, investors worry about the lack of clear AI-driven monetiza...

Space-focused ETF NASA surpasses $1B AUM in weeks, driven by SpaceX hype and commercial space growth.
The Tema Space Innovators ETF (NASA) has rapidly grown from $1 million to over $1 billion in assets under management within just 37 trading days, fueled by investor demand for exposure to SpaceX ahead of its anticipated IPO. Unlike other space ETFs, ...
